LSD could be approved for treating anxiety in the US as soon as 2027. This expectation comes after a landmark trial showed that a single dose of the psychedelic drug eased the mental health condition ...

Drug also treated depression in June trial Consistent late-stage successes unusual in neuropsychiatry - analyst Definium plans FDA filing in first half of 2027 Sept 14 (Reuters) - Definium ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

University of California, Davis, researchers have stripped down LSD to the base features responsible for its hallucinogenic and therapeutic effects. In a study published in Proceedings of the National ...

University of California, Davis, researchers have stripped down LSD to the base features responsible for its hallucinogenic and therapeutic effects. In a study published in Proceedings of the National ...

Aug 12 (Reuters) - Definium Therapeutics' (DFTX.O), opens new tab LSD-based experimental pill exceeded investor expectations by significantly reducing anxiety symptoms in a late-stage study, meeting ...

Lysergic acid diethylamide (LSD) has joined a growing list of potent serotonergic system psychedelics that have emerged as promising treatments for some psychiatric disorders, including major ...

People taking Definium Therapeutics' DT120 showed long-lasting reductions in their depression symptoms compared to a placebo, the company announced Monday. Reading time 3 minutes The future of mental ...

Three fighters transported to hospital after super-violent UFC 332, broken jaw confirmed Better to be safe than sorry … Following UFC 332 last night (Sat., Oct. 3, 2026) inside Delta Center in Salt ...

University of Auckland researchers report that an 8-week, twice-weekly LSD microdosing regimen for major depressive disorder was feasible and well-tolerated, with Montgomery-Åsberg Depression Rating ...

LSD reduced symptoms of anxiety in a midstage study published Thursday, paving the way for additional testing and possible medical approval of a psychedelic drug that has been banned in the U.S. for ...

A mid-stage study of a pharmaceutical version of the psychedelic LSD reported the drug might help alleviate anxiety symptoms for up to three months, advancing a potential treatment for the most common ...